Socioeconomic disadvantage and polygenic risk for high BMI magnify obesity risk across childhood: a longitudinal, population, cohort study.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 7 3 2023
Statut: ppublish

Résumé

Across the life course, socioeconomic disadvantage disproportionately afflicts those with genetic predispositions to inflammatory diseases. We describe how socioeconomic disadvantage and polygenic risk for high BMI magnify the risk of obesity across childhood, and using causal analyses, explore the hypothetical impact of intervening on socioeconomic disadvantage to reduce adolescent obesity. Data were drawn from a nationally representative Australian birth cohort, with biennial data collection between 2004 and 2018 (research and ethics committee approved). We generated a polygenic risk score for BMI using published genome-wide association studies. We measured early-childhood disadvantage (age 2-3 years) with a neighbourhood census-based measure and a family-level composite of parent income, occupation, and education. We used generalised linear regression (Poisson-log link) to estimate the risk of overweight or obesity (BMI ≥85th percentile) at age 14-15 years for children with early-childhood disadvantage (quintiles 4-5) versus average (quintile 3) and least disadvantage (quintiles 1-2), for those with high and low polygenic risk separately. For 1607 children (n=796 female, n=811 male; 31% of the original cohort [N=5107]), polygenic risk and disadvantage were both associated with overweight or obesity; effects of disadvantage were more marked as polygenic risk increased. Of children with polygenic risk higher than the median (n=805), 37% of children living in disadvantage at age 2-3 years had an overweight or obese BMI by adolescence, compared with 26% of those with least disadvantage. For genetically vulnerable children, causal analyses indicated that early neighbourhood intervention to lessen disadvantage (to quintile 1-2) would reduce risk of adolescent overweight or obesity by 23% (risk ratio 0·77; 95% CI 0·57-1·04); estimates for improving family environments were similar (0·59; 0·43-0·80). Actions addressing socioeconomic disadvantage could mitigate polygenic risk for developing obesity. This study benefits from population-representative longitudinal data but is limited by sample size. Australian National Health and Medical Research Council.

Sections du résumé

BACKGROUND
Across the life course, socioeconomic disadvantage disproportionately afflicts those with genetic predispositions to inflammatory diseases. We describe how socioeconomic disadvantage and polygenic risk for high BMI magnify the risk of obesity across childhood, and using causal analyses, explore the hypothetical impact of intervening on socioeconomic disadvantage to reduce adolescent obesity.
METHODS
Data were drawn from a nationally representative Australian birth cohort, with biennial data collection between 2004 and 2018 (research and ethics committee approved). We generated a polygenic risk score for BMI using published genome-wide association studies. We measured early-childhood disadvantage (age 2-3 years) with a neighbourhood census-based measure and a family-level composite of parent income, occupation, and education. We used generalised linear regression (Poisson-log link) to estimate the risk of overweight or obesity (BMI ≥85th percentile) at age 14-15 years for children with early-childhood disadvantage (quintiles 4-5) versus average (quintile 3) and least disadvantage (quintiles 1-2), for those with high and low polygenic risk separately.
FINDINGS
For 1607 children (n=796 female, n=811 male; 31% of the original cohort [N=5107]), polygenic risk and disadvantage were both associated with overweight or obesity; effects of disadvantage were more marked as polygenic risk increased. Of children with polygenic risk higher than the median (n=805), 37% of children living in disadvantage at age 2-3 years had an overweight or obese BMI by adolescence, compared with 26% of those with least disadvantage. For genetically vulnerable children, causal analyses indicated that early neighbourhood intervention to lessen disadvantage (to quintile 1-2) would reduce risk of adolescent overweight or obesity by 23% (risk ratio 0·77; 95% CI 0·57-1·04); estimates for improving family environments were similar (0·59; 0·43-0·80).
INTERPRETATION
Actions addressing socioeconomic disadvantage could mitigate polygenic risk for developing obesity. This study benefits from population-representative longitudinal data but is limited by sample size.
FUNDING
Australian National Health and Medical Research Council.

Identifiants

pubmed: 36866486
pii: S2214-109X(23)00094-3
doi: 10.1016/S2214-109X(23)00094-3
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S9-S10

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Jessica A Kerr (JA)

Department of Psychological Medicine, University of Otago Christchurch, Christchurch, New Zealand; Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia. Electronic address: jessica.kerr@otago.ac.nz.

Dorothea Dumuid (D)

Alliance for Research in Exercise, University of South Australia, Adelaide, SA, Australia.

Marnie Downes (M)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Katherine Lange (K)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia.

Meredith O'Connor (M)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia.

Lukar Thornton (L)

Department of Marketing, University of Antwerp, Antwerp, Belgium.

Suzanne Mavoa (S)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Environment Protection Authority Victoria, Melbourne, VIC, Australia.

Kate Lycett (K)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia; School of Psychology, Deakin University, Burwood, VIC, Australia.

Tim S Olds (TS)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Alliance for Research in Exercise, University of South Australia, Adelaide, SA, Australia.

Ben Edwards (B)

Centre for Social Research and Methods, Australian National University, Canberra, ACT, Australia.

Justin M O'Sullivan (JM)

Department of Pediatrics and The Liggins Institute, University of Auckland, Auckland, New Zealand; The Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand; Australian Parkinson's Mission, Garvan Institute of Medical Research, Sydney, NSW, Australia; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; Agency for Science Technology and Research, Singapore Institute for Clinical Sciences, Singapore.

Markus Juonala (M)

Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Medicine, University of Turku, Turku, Finland; Division of Medicine, Turku University Hospital, Turku, Finland.

David Burgner (D)

Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia; Department of Pediatrics, Monash University, Melbourne, Australia.

Melissa Wake (M)

Population Health Theme, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia; Department of Pediatrics and The Liggins Institute, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH